Cadence Design Systems Acquires OpenEye Scientific

Cadence Design Systems entered into a definitive agreement to acquire OpenEye Scientific Software, a provider of computational molecular modeling and simulation software used in pharmaceutical and biotechnology drug discovery. The deal is valued at approximately $500 million in cash and was expected to close in Q3 2022 (subject to customary conditions). Cadence later announced it completed the acquisition.